Jue Pu
Net worth: 49 M $ as of 31/05/2026
Net worth: 49 M $ as of 31/05/2026
Jue Pu was the founder of CG Oncology, Inc. (2010) and served as Director from 2010 to 2018.
Current jobs include Director at Inspirna, Inc. since 2018 and Non-Executive Director at Lepu Biopharma Co., Ltd. since 2020.
Former job included Director at CG Oncology, Inc. from 2019 to 2023.
Education includes a graduate degree from Stanford University (2013) and an undergraduate degree from The Wharton School of the University of Pennsylvania (2012).
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 21/07/2025 | 90,000,000 ( 4.99% ) | 49 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| LEPU BIOPHARMA CO., LTD. | Director/Board Member | 22/04/2020 |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for cancer | Director/Board Member | 01/10/2018 |
| Companies | Position | End |
|---|---|---|
| CG ONCOLOGY, INC. | Director/Board Member | 01/10/2023 |
| CG ONCOLOGY, INC. | Founder | 01/01/2018 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CG Oncology, Inc.
CG Oncology, Inc. BiotechnologyHealth Technology Operates as a late-stage clinical biopharmaceutical company focused on developing and commercializing backbone bladder-sparing therapeutic | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for cancer | Health Technology |
Lepu Biopharma Co., Ltd.
Lepu Biopharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Select your edition
All financial news and data tailored to specific country editions